CLINICAL_TRIALS
trial_result
· 2018-07-19
Clinical Trial Update: Psychopharmacology of Psilocybin in Cancer Patients [Phase 2]
Summary
Phase 2 trial evaluating psilocybin for depressive symptoms and anxiety in cancer patients has completed, with results posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Johns Hopkins University | Conditions: Depressive Symptoms, Anxiety | Phase 2 | Status: COMPLETED | Results posted: 2018-07-19